Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations
Clinical trial NCT02278133 · COMPLETED
Trial details
- NCT number
- NCT02278133
- Sponsor
- Array BioPharma
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-05-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.